We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BILL icon
126
BILL Holdings
BILL
$4.19B
$6.57M 0.08%
181,617
-193,291
-52% -$7.12M
ROST icon
127
Ross Stores
ROST
$73.7B
$6.14M 0.08%
28,865
-19,043
-40% -$4.28M
RPID icon
128
Rapid Micro Biosystems
RPID
$65.7M
$5.76M 0.07%
+3,328,000
New +$7.01M
CTOR
129
Citius Oncology
CTOR
$91M
$5.66M 0.07%
8,705,589
-483,266
-5% -$385K
ORLY icon
130
O'Reilly Automotive
ORLY
$71.1B
$5.31M 0.07%
57,689
-20,414
-26% -$1.86M
RTB
131
RTB Digital
RTB
$160M
$5.28M 0.06%
+350,000
New +$2.28M
AMAT icon
132
Applied Materials
AMAT
$361B
$5.12M 0.06%
7,084
-9,419
-57% -$4.35M
DWTX
133
Dogwood Therapeutics
DWTX
$77.8M
$5.04M 0.06%
3,132,486
-147,514
-4% -$244K
LIVN icon
134
LivaNova
LIVN
$4.51B
$4.81M 0.06%
+58,451
New +$4.13M
PONY
135
Pony AI Inc
PONY
$3.19B
$4.52M 0.06%
650,000
+114,000
+21% +$1.06M
BTSG icon
136
BrightSpring Health Services
BTSG
$12B
$4.42M 0.05%
+63,409
New +$3.52M
TSEM icon
137
Tower Semiconductor
TSEM
$25.1B
$4.22M 0.05%
16,199
+1,319
+9% +$316K
MCK icon
138
McKesson
MCK
$106B
$4.19M 0.05%
+5,551
New +$4.4M
ESLA icon
139
Estrella Immunopharma
ESLA
$28.1M
$4.13M 0.05%
3,975,220
-123,780
-3% -$162K
CRMD icon
140
CorMedix
CRMD
$657M
$3.92M 0.05%
+500,000
New +$3.95M
LEVI icon
141
Levi Strauss
LEVI
$8.1B
$3.92M 0.05%
158,000
-60,000
-28% -$1.35M
DHR icon
142
Danaher
DHR
$146B
$3.9M 0.05%
+20,500
New +$3.72M
LSCC icon
143
Lattice Semiconductor
LSCC
$16.5B
$3.74M 0.05%
+24,436
New +$3.15M
STX icon
144
Seagate
STX
$192B
$3.73M 0.05%
3,867
-7,816
-67% -$5.96M
SNDK
145
Sandisk
SNDK
$255B
$3.68M 0.05%
1,620
-4,230
-72% -$6.04M
LRCX icon
146
Lam Research
LRCX
$385B
$3.59M 0.04%
8,283
-15,669
-65% -$4.76M
TTMI icon
147
TTM Technologies
TTMI
$13.2B
$3.56M 0.04%
+19,027
New +$3.07M
LITE icon
148
Lumentum
LITE
$79B
$3.24M 0.04%
3,773
-2,292
-38% -$2.04M
WDC icon
149
Western Digital
WDC
$169B
$3.21M 0.04%
5,023
-12,862
-72% -$6.25M
STM icon
150
STMicroelectronics
STM
$46.6B
$3.15M 0.04%
+42,036
New +$2.53M
4 5
6
7 8

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.